Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07490522Not ApplicableRecruiting

The Remote Monitoring of Gout Feasibility Study in Primary Care

Role: collaborator

NCT04617639Not ApplicableEnrolling By Invitation

The Norwegian Trial of Physical Exercise After Myocardial Infarction

Role: collaborator

NCT06649136Phase 4Recruiting

MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients with Active Rheumatoid Arthritis

Role: collaborator

All 3 trials loaded